Bridging the gap: neurodevelopmental disorder risks in inborn errors of immunity

Devika Kurup,Amy M. FitzPatrick,Aleksandra Badura,Ines Serra
DOI: https://doi.org/10.1097/aci.0000000000001036
2024-10-05
Current Opinion in Allergy and Clinical Immunology
Abstract:Inborn errors of immunity (IEI) are characterized by increased susceptibility to infections, autoimmunity, atopy, and malignancies. Although each disease is individually rare, IEIs as a group affect between 1 : 1000 and 1 : 5000 people [1▪] . IEI research has predominantly focused on the immunological and oncological manifestations, genetic causes, and treatment options, which range from immunoglobulin replacement to hematopoietic stem cell transplant [2,3,8] . In recent years, however, there has been growing interest in multiorgan presentations, with reports describing comorbidities of the central nervous, gastrointestinal, and hepatic systems [1▪,2] .
immunology,allergy
What problem does this paper attempt to address?